Serum miR-125a-5p and CCL17 Upregulated in Chronic Spontaneous Urticaria and Correlated with Treatment Response

Serum miR-125a-5p and CCL17 Upregulated in Chronic Spontaneous Urticaria and Correlated with Treatment Response

Chronic spontaneous urticaria (CSU) is a common skin disorder associated with autoimmunity. MicroRNAs (miRNAs) are endogenous noncoding RNA molecules reported to be potential biomarkers for some autoimmune diseases. In this study, we investigated the association of miRNAs with CSU. A quantitative PC...

Full description

Bibliographic Details
Main Authors:	Liming Zhang, Ruiqun Qi, Yang Yang, Xinghua Gao, Hongduo Chen, Ting Xiao
Format:	Article
Language:	English
Published:	Medical Journals Sweden 2019-03-01
Series:	Acta Dermato-Venereologica
Subjects:	chronic spontaneous urticaria chronic idiopathic urticaria miR-125a-5p CCL17 IL-17
Online Access:	https://www.medicaljournals.se/acta/content/html/10.2340/00015555-3149

Similar Items

Cytokine Profiles of Chronic Urticaria Patients and the Effects of Omalizumab Treatment
by: Ozge Can Bostan, et al.
Published: (2023-10-01)

COVID-19 infection in chronic spontaneous urticaria treated with omalizumab: two case reports
by: Angelo Massimiliano D'Erme, et al.
Published: (2023-08-01)

The Expression of IL-17, in Chronic Spontaneous Urticaria Is Linked to Semaphorin5A
by: Matanis Lobna, et al.
Published: (2021-03-01)

Omalizumab for the management of refractory chronic spontaneous urticaria
by: P C Kathuria, et al.
Published: (2022-01-01)

The correlation between Th17/Treg immune dysregulation and the disease severity in chronic spontaneous urticaria patients
by: Xiaojing Yang, et al.
Published: (2023-07-01)

Comparative study of efficacy and safety of cetirizine and bilastine in patients of chronic spontaneous urticaria: Open-label, randomized, parallel-group study
by: Vishakha V Sinha, et al.
Published: (2023-01-01)

Real-life data on the effectiveness and safety of omalizumab in monotherapy or combined for chronic spontaneous urticaria: a retrospective cohort study
by: Andac Salman, et al.
Published: (2020-02-01)

Atopy in chronic urticaria: an important yet overlooked issue
by: Qiquan Chen, et al.
Published: (2024-02-01)

Brain Injury Associated with Chronic Spontaneous Urticaria: a Kounis-Like Syndrome?
by: Luis Santiago, et al.
Published: (2020-01-01)

Advances in the applications of biologics in the treatment of chronic spontaneous urticaria
by: Xuemei HUANG, et al.
Published: (2024-02-01)

Omalizumab treatment for chronic spontaneous urticaria: data from Turkey
by: Rabia Kara, et al.
Published: (2022-09-01)

Retrospective analysis of the treatment of 61 cases of chronic spontaneous urticaria with omalizumab
by: Shanshan OU, et al.
Published: (2023-04-01)

Current and Emerging Therapies for Chronic Spontaneous Urticaria: A Narrative Review
by: Gil Yosipovitch, et al.
Published: (2023-06-01)

Omalizumab in the treatment of chronic spontaneous urticaria – literature review and own experience
by: Joanna Dawicka, et al.
Published: (2016-02-01)

Type I and type IIb autoimmune chronic spontaneous urticaria: Using common clinical tools for endotyping patients with CSU
by: Juliana A. Sella, MD, PhD, et al.
Published: (2023-11-01)

Cyclosporine for omalizumab-refractory chronic urticaria: a report of five cases
by: Anthony F. LaCava, et al.
Published: (2023-08-01)

Differential diagnosis between urticarial vasculitis and chronic spontaneous urticaria: An international Delphi survey
by: Karoline Krause, et al.
Published: (2023-10-01)

Psychosocial factors and chronic spontaneous urticaria: a systematic review
by: Jennifer Donnelly, et al.
Published: (2023-08-01)

A survey of treatment practices in management of chronic urticaria patients among dermatologists of India
by: B M Shashi Kumar, et al.
Published: (2024-01-01)

Complete response to dupilumab in a patient with chronic spontaneous urticaria who did not tolerate omalizumab
by: Changhua Zhu, MD, et al.
Published: (2023-02-01)

Omalizumab's efficacy and safety against chronic spontaneous urticaria
by: Öner Özdemir
Published: (2023-08-01)

Impact of Chronic Spontaneous or Inducible Urticaria on Occupational Activity
by: Amandine Baudy, et al.
Published: (2024-03-01)

Levels of serum inflammatory cytokines and their correlations with disease severity in patients with chronic spontaneous urticaria
by: Wenming Zeng, et al.
Published: (2024-03-01)

Chronic spontaneous urticaria treated with omalizumab: report of two cases
by: Giovanna Malara, et al.
Published: (2018-12-01)

A novel case of chronic spontaneous urticaria associated chronic myelogenous leukemia with rapid resolution upon treatment with imatinib
by: Alexis Tracy, MD, et al.
Published: (2022-12-01)

Comparative analysis of clinical and laboratory parameters of autoimmune and idiopathic chronic urticaria patients
by: Ninković-Baroš Đuka, et al.
Published: (2021-01-01)

Chronic spontaneous urticaria or autoinflammatory disease? The therapeutic effect of omalizumab in a pediatric patient
by: Maria Cristina Maggio, et al.
Published: (2018-12-01)

Focus on the role of substance P in chronic urticaria
by: Gino A. Vena, et al.
Published: (2018-11-01)

Omalizumab in chronic spontaneous urticaria: steroid sparing effect
by: Alessia Gatta, et al.
Published: (2018-12-01)

Evaluation of Pediatric Chronic Urticaria with Emphasis on Clinical and Laboratory Characteristics and Treatment Response to Omalizumab: A Real-Life Experience from a Tertiary Allergy Center
by: Aylin Kont Özhan, et al.
Published: (2024-01-01)

Prevalence of Autoimmune and Autoinflammatory Diseases in Chronic Urticaria: Pathogenetic, Diagnostic and Therapeutic Implications
by: Giuseppe Murdaca, et al.
Published: (2023-01-01)

Acute and Chronic Urticaria: Prevalence, Etiologies, Diagnosis, and Treatment
by: Javad Ghaffari, et al.
Published: (2020-07-01)

Clinical observation of desloratadine combined with omalizumab in the treatment of chronic spontaneous urticaria
by: Zhiwei SHANG, et al.
Published: (2022-02-01)

Clinical and anamnestic differences between acute and chronic urticaria in children
by: R. M. Faizullina, et al.
Published: (2021-07-01)

Effective treatment with omalizumab of a patient with spontaneous chronic urticaria and eosinophilic esophagitis
by: Eugenio Provenzano, et al.
Published: (2018-12-01)

Chronic Urticaria Treatment with Omalizumab—Verification of NLR, PLR, SIRI and SII as Biomarkers and Predictors of Treatment Efficacy
by: Bartłomiej Tarkowski, et al.
Published: (2023-04-01)

The use of an urticaria control test for the evaluation of omalizumab treatment response in patients diagnosed with chronic urticaria
by: Burhan Engin, et al.
Published: (2020-12-01)

Clinical review: The suggested management pathway for urticaria in primary care
by: Dermot Ryan, et al.
Published: (2022-10-01)

Recurrent oedema of the uvula in a patient with chronic spontaneous urticaria successfully treated with omalizumab
by: Alessandro Pannofino
Published: (2018-12-01)

Omalizumab for the treatment of chronic spontaneous urticaria: association between body mass index and outcome
by: Irene Russo, et al.
Published: (2022-10-01)